Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Status:
RECRUITING
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
The study aims to evaluate the burden of tau pathology in people with Sporadic and LRRK2 PD via in vivo imaging using the tau tracer, \[18F\]PI-2620, and a high resolution PET camera, NeuroEXPLORER.
Phase:
PHASE2
Details
Lead Sponsor:
Michael J. Fox Foundation for Parkinson's Research